A highly efficient synthesis of the potent and selective NK-1 receptor antagonist
1 is described. The keytransformation involved the etherification reaction between cyclopentanol
12 and chiral imidate
30 whichwas catalyzed by HBF
4 to initially give ether
14 as a 17:1 mixture of diastereomers and in 75% combinedyield. The diastereoselectivity was upgraded to 109:1 by crystallization of the triethylamine solvate
44which was isolated in 54% yield from
12. Mechanistic studies confirmed that the etherification reactionproceeds through an unprecedented S
N2 reaction pathway under typical S
N1 reaction conditions.